|
Book
Chapters
Clinical Examination.Owen
Epstein G.David Perkin John Cookson Ian S. Watt Roby Rakhit Andrew W.
Robins, Graham A. W. Hornett . Fourth Edition. Mosby Elsevier 2008.
Stent versus angioplasty:
indication for stents in stable angina. Part III p. 115 - 129. In: The
Year In Interventional Cardiology. Eds: H. White, P De Feijter, B. Meier
A. Colombo, A. Banning, R.Schräder. Clinical Publishing Services,
Oxford 2002.
Original Scientific Studies
1. Bhattacharyya
MR, Whitehead DL, Rakhit R, Steptoe A. Depressed Mood, Positive
Affect, and Heart Rate Variability in Patients With Suspected Coronary
Artery Disease. Psychosom Med 2008; 70: 1020-1027.
2. Rakhit RD, Wustmann
K, Zbinden S, Printzen G, Windecker S, Meier B,
Seiler C, Eberli FR. Tumor necrosis factor-alpha and interleukin-6 release
during primary percutaneous coronary intervention for acute myocardial
infarction is related to coronary collaterals. Coron Artery Dis 2005;16:147-52.
3. Dalby M, Davies
J, Rakhit RD, Mayet J, Foale R, Davies DW. Feasibility and safety of day
case transfemoral coronary stenting. Cardiovasc Catheter Interventions
2003;60: 8-24.
4. Rakhit RD, Meier
B, Matter C, Garachemani A, Windecker S, Seiler C, Eberli FR. Five French
versus six French PCI: A case-control study of efficacy, safety and outcome.
J Invasive Cardiology 2002;14:670-4.
5. Edwards RJ, Redwood
SR, Lambiase PD, Tomset E, Rakhit RD, Marber MS. Anti-arrhythmic and anti-ischaemic
effects of angina in patients with and without coronary collaterals. Heart
2002;88:604-10.
6. Rakhit RD, Mojet
MH, Marber MS, Duchen MR. Mitochondria as targets for nitric oxide induced
protection during simulated ischemia and reoxygenation in isolated neonatal
cardiomyocytes. Circulation 2001;103:2617-2623.
7. Rakhit RD, Kabir
AN, Mockridge JW, Saurin A, Marber MS. Role of G proteins and modulation
of p38 MAPK activation in the protection by nitric oxide against ischemia-reoxygenation
injury. Biochem Biophys Res Commun 2001;286:995-1002.
8. Rakhit RD, Edwards
RJ, Mockridge J, Baydoun A, Wyatt A, Mann GE, Marber MS. Nitric oxide-induced
cardioprotection in cultured rat ventricular myocytes. Am J Physiol 2000;278:H1211-H1217.
9. Rakhit RD, Tousoulis
D, Le Froy DC and Davies GJ. Differential nitric oxide synthase activity
in ischemic and idiopathic dilated cardiomyopathy. Am J Cardiol 1999;84:737-738.
10. Edwards RJ, Youseff
Z, Rakhit RD, Wright M, Rosenthal E, Redwood S, Marber MS. A model of
closed chest regional myocardial infarction in the rabbit: a clinically
relevant in vivo assay system of post-infarction remodeling. Basic Res
Cardiol 2002;97:374-383.
11. Gorog D, Rakhit
RD, Parums D, Laffan M, Davies GJ. Raised factor VIII is associated with
coronary thrombotic events. Heart 1998;80:415-417.
12. Stables RH for
the Brompton House Officer Audit Group: Choudhury RP, Davies WG, Denton
MD, Ledson M, Rakhit RD, Varma C. An audit of lipid screening and management
in patients undergoing diagnostic cardiac catheterisation. Eur Heart J
1996;17:1657-1662.
13. Kapur N, Lambiase
P, Rakhit RD, Pearce J, Orchard G, Calonje E, Dowd PM. Local and systemic
expression of fibroblast growth factor in familial multiple glomangioma.
Br J Dermatol 2002;146:518-522.
Reviews
1. Rakhit RD and Marber
MS. Nitric oxide - an emerging role in cardioprotection? Heart 2001;86(4):368-72.
2. Rakhit RD, Edwards
RJ, Marber MS. Review: Nitric oxide, nitrates and ischaemic preconditioning
Cardiovascular Research 1999;43:621-627.
3. Edwards RJ, Saurin
AT, Rakhit RD, Marber MS. Therapeutic potential of ischaemic preconditioning.
Br J Clin Pharmacol 2000;50:87-97.
4. McCabe DJH and
Rakhit RD. Anti-thrombotic and interventional treatment options in cardioembolic
TIA and stroke. Accepted for publication in J Neurol, Neurosurg &
Psych 2007;78:14-24.
Case
Reports
1. Booth JW, Rakhit
RD, Cropley I, Hurst JR. Westermark`s Sign in Submassive Pulmonary Embolism.
Eur Heart J. 2009 Jan;30(1):98-106.
2. Hadjiloizou N,
Rakhit R. Frovatriptan, a probale cause of coronary vasoconstriction.
Intl J Clin Pract. 2008 Jul;62(7):1121-2.
3. Rakhit RD. Patent
foramen ovale (PFO) and paradoxical embolism (Interactive Case). Heart.
2003;89:1362.
4. Rakhit RD, Heinein
M, Sheppard MN, Gibson DG. Restrictive pericarditis Heart 1999;82:389-392.
5. Rakhit RD, Clesham
GJ, Cleland GJF. Sarcoid, amyloid and heart failure. Int. J.Cardiol. 1993;41:180-182.
6. Rakhit RD, Sethi
D, Woodrow DF, Phillips ME. Complications of "skin popping"
in a British heroin addict. Nephrology, Dialysis and Transplantation.
1993;8:572-573.
Research
Letters
1. Bhattacharyya S,
Rakhit R. Cytochrome P450 2C19 polymorphism and clopidogrel after MI.
Lancet. 2009 Apr 4;373(9670):1171
2. Rakhit RD, Beck
R, Foster O, Thompson AJ, Kendall B. Resolution of lower limb neurological
deficit in spinal arteriovenous malformation with penile papaverine. Lancet
1993;341:490.
3. Edwards RJ, Rakhit
RD, Marber MS. Diabetes and coronary disease: time to stop taking the
tablets. Heart 1999;81:674.
|